Two Cases of Super-Giant Coronary Aneurysms after Kawasaki Disease |
Lee, Joowon
(Department of Pediatrics, Seoul National University Children's Hospital)
Kim, Gi Beom (Department of Pediatrics, Seoul National University Children's Hospital) Kwon, Bo Sang (Department of Pediatrics, Seoul National University Children's Hospital) Bae, Eun Jung (Department of Pediatrics, Seoul National University Children's Hospital) Noh, Chung Il (Department of Pediatrics, Seoul National University Children's Hospital) |
1 | Burns JC, Kushner HI, Bastian JF, et al. Kawasaki disease: a brief history. Pediatrics 2000;106:E27. DOI ScienceOn |
2 | Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004;364:533-44. DOI ScienceOn |
3 | Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85. DOI ScienceOn |
4 | Suda K, Kudo Y, Higaki T, et al. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ J 2009;73: 1319-23. DOI |
5 | Imai Y, Sunagawa K, Ayusawa M, et al. A fatal case of ruptured giant coronary artery aneurysm. Eur J Pediatr 2006;165:130-3. DOI |
6 | Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 2012;22:79-85. DOI |
7 | McNeal-Davidson A, Fournier A, Scuccimarri R, et al. The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976. Pediatr Cardiol 2013;34:170-8. DOI |
8 | Suzuki N, Seguchi M, Kouno C, Inukai K, Kito H, Kobayashi H. Rupture of coronary aneurysm in Kawasaki disease. Pediatr Int 1999;41:318-20. DOI |
9 | Panzer J, De Jaeger A, Suys B. Rupture of giant coronary arterial aneurysm without progressive dilation. Cardiol Young 2008;18:189-90. |
10 | Sunagawa K, Mitsumata M, Ayusawa M, Kusumi Y. Ruptured giant aneurysm of the left anterior descending coronary artery in Kawasaki disease. Pediatr Cardiol 2008;29:1115-9. DOI |
11 | Kuramochi Y, Ohkubo T, Takechi N, Fukumi D, Uchikoba Y, Ogawa S. Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatr Int 2000;42:470-5. DOI ScienceOn |
12 | Ohkubo T, Fukazawa R, Ikegami E, Ogawa S. Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations. Pediatr Int 2007;49:1-7. DOI |
13 | Kato H, Inoue O, Ichinose E, Akagi T, Sato N. Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction. Acta Paediatr Jpn 1991;33:27-35. DOI |
14 | Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979;63:175-9. |
15 | Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 2012;379:1613-20. DOI |
16 | Chen S, Dong Y, Yin Y, Krucoff MW. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart 2013;99:76-82. DOI |
17 | Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001; 43:211-7. DOI |